CONMED Corp. (CNMD)

60.41
0.09 0.15
NASDAQ : Health Technology
Prev Close 60.50
Open 60.71
Day Low/High 59.97 / 60.71
52 Wk Low/High 39.74 / 64.99
Volume 136.21K
Avg Volume 160.80K
Exchange NASDAQ
Shares Outstanding 27.93M
Market Cap 1.71B
EPS 2.00
P/E Ratio 30.96
Div & Yield 0.80 (1.31%)

Latest News

CONMED Corporation Announces Fourth Quarter And Fiscal Year 2017 Financial Results

CONMED Corporation Announces Fourth Quarter And Fiscal Year 2017 Financial Results

CONMED Corporation (Nasdaq:CNMD) today announced financial results for the fourth quarter and fiscal year ended December 31, 2017.

CONMED Corporation To Announce Fourth Quarter And Fiscal Year 2017 Financial Results On January 31, 2018

CONMED Corporation To Announce Fourth Quarter And Fiscal Year 2017 Financial Results On January 31, 2018

CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the fourth quarter and fiscal year 2017 after the market close on Wednesday, January 31, 2018.

CNMD Crosses Above Average Analyst Target

In recent trading, shares of Conmed Corp. have crossed above the average analyst 12-month target price of $53.50, changing hands for $54.14/share.

CONMED Corporation Appoints Todd W. Garner As Executive Vice President And Chief Financial Officer

CONMED Corporation Appoints Todd W. Garner As Executive Vice President And Chief Financial Officer

CONMED Corporation (NASDAQ:CNMD) today announced that it has appointed Todd W.

CONMED Corporation To Present At The J.P. Morgan Healthcare Conference

CONMED Corporation To Present At The J.P. Morgan Healthcare Conference

CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A.

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation (NASDAQ: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.

CONMED Corporation Announces Retirement Of Chief Financial Officer

CONMED Corporation Announces Retirement Of Chief Financial Officer

CONMED Corporation (NASDAQ: CNMD) today announced that Luke A. Pomilio, Executive Vice President, Finance and Chief Financial Officer, has decided to retire after over two decades of service with the Company.

CONMED Corporation Announces Third Quarter 2017 Financial Results

CONMED Corporation Announces Third Quarter 2017 Financial Results

CONMED Corporation (Nasdaq:CNMD) today announced financial results for the third quarter ended September 30, 2017.

CONMED Corporation To Announce Third Quarter 2017 Financial Results On November 2, 2017

CONMED Corporation To Announce Third Quarter 2017 Financial Results On November 2, 2017

CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the third quarter of fiscal year 2017 after the market close on Thursday, November 2, 2017.

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation (NASDAQ:CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.

CONMED Corporation To Present At The Morgan Stanley Global Healthcare Conference

CONMED Corporation To Present At The Morgan Stanley Global Healthcare Conference

CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AEL, CNMD, DATA, IAC, KBR, KHC, KOP, NPO, PBR.A, REG, SHAK, SQ, STOR, WMS, XPO Downgrades: ABC, AXTA, BIO, BIO.B, CNSL, DISH, GNE, HL, MCS, TGP, TNK, WEYS, WRLD Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

CONMED Corporation Announces Second Quarter 2017 Financial Results

CONMED Corporation Announces Second Quarter 2017 Financial Results

CONMED Corporation (Nasdaq:CNMD) today announced financial results for the second quarter ended June 30, 2017.

CONMED Corporation To Announce Second Quarter 2017 Financial Results On July 26, 2017

CONMED Corporation To Announce Second Quarter 2017 Financial Results On July 26, 2017

CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the second quarter of fiscal year 2017 after the market close on Wednesday, July 26, 2017.

CNMD Crosses Above Average Analyst Target

In recent trading, shares of Conmed Corp. have crossed above the average analyst 12-month target price of $50.30, changing hands for $50.95/share.

Conmed Reaches Analyst Target Price

In recent trading, shares of Conmed Corp. have crossed above the average analyst 12-month target price of $50.30, changing hands for $50.55/share.

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation (NASDAQ:CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.

CONMED Corporation Announces First Quarter 2017 Financial Results

CONMED Corporation (Nasdaq:CNMD) today announced financial results for the first quarter ended March 31, 2017.

CONMED Corporation To Present At The Deutsche Bank 42nd Annual Health Care Conference

CONMED Corporation (NASDAQ: CNMD) today announced that Luke A. Pomilio, Chief Financial Officer, and Patrick J.

CONMED Corporation Announces Jury Verdict In Delaware Litigation Against SurgiQuest

CONMED Corporation (NASDAQ:CNMD) today announced that a jury in the United State Federal District Court for the District of Delaware returned a verdict finding CONMED's subsidiary, SurgiQuest, liable for $2.

CONMED Corporation To Announce First Quarter 2017 Financial Results On April 26, 2017

CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the first quarter of fiscal year 2017 after the market close on Wednesday, April 26, 2017.

CONMED Corporation Announces Annual Meeting Of Shareholders

CONMED Corporation (NASDAQ: CNMD) today announced that its Annual Meeting of Shareholders will be held at the Company's corporate offices, 525 French Road, Utica, NY on Wednesday, May 24, 2017, at 12:00 p.

CNMD: Insiders vs. Shorts

The most recent short interest data was recently released for the 01/31/2017 settlement date, and Conmed Corp. is one of the most shorted stocks of the Russell 3000, based on 12.09 "days to cover" versus the median component at 5.13.

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation (NASDAQ: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.

CONMED Corporation Announces Fourth Quarter And Fiscal Year 2016 Financial Results

CONMED Corporation (Nasdaq:CNMD) today announced financial results for the fourth quarter and fiscal year ended December 31, 2016.

Voce's Plants Eyes Stockholder Value, Director Battle at Air Methods

Voce's Plants Eyes Stockholder Value, Director Battle at Air Methods

The activist investor turned up the heat on his multi-year effort at the emergency medical air transportation company.

CONMED Corporation To Present At The Leerink Partners 6th Annual Global Healthcare Conference

CONMED Corporation To Present At The Leerink Partners 6th Annual Global Healthcare Conference

CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A.

TheStreet Quant Rating: A- (Buy)